Expert Review of Gastroenterology & HepatologyTack J.Prucalopride: a new drug for the treatment of chronic constipation.Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):337~343Tack J. Prucalopride: a new drug for the treatment of chronic constipation. Expert Rev Gastroenterol Hepatol 2009;3:337-...
Prucalopride: a new drug for the treatment of chronic constipation. Prucalopride belongs to a novel class of 5-hydroxytryptamine-4 receptor agonists, and has been evaluated extensively for the treatment of chronic constipat... Tack,Jan - 《Expert Review of Gastroenterology & Hepatology》 被引量: ...
Prucalopride (R093877) is a drug acting as a selective, high affinity 5-HT4 receptor agonist(pKi=8.6/8.1 for 5-HT4a/4b); >150-fold higher affinity for 5-HT4 receptors than for other receptors.IC50 value: 8.6/8.1 for 5-HT4a/4b(pKi)Target: 5-HT4 receptorPrucalopride is a novel ent...
Drug SummaryWhat Is Motegrity? Motegrity (prucalopride) is a serotonin-4 (5-HT4) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. What Are Side Effects of Motegrity? Motegrity may cause serious side effects including: hives, difficulty breathing, ...
Drug SummaryWhat Is Motegrity? Motegrity (prucalopride) is a serotonin-4 (5-HT4) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. What Are Side Effects of Motegrity? Motegrity may cause serious side effects including: hives, difficulty breathing, ...
It is effective, safe and shows good tolerance for the treatment of men with chronic constipation. Enzyme inhibitor This novel enterokinetic drug (FW = 367.87 g/mol; CAS 179474-81-8), also known by the tradename Resolor? and its systematic name, 4-amino-5- chloro-N-[1-(3-methoxypropyl...
Alternatively, it is possible that the dose of the drug was too small to exert more important stim- ulatory effects on the large bowel. Thus, even though this was a pilot trial conducted on a limited sample size, we feel these effects might be of clinical interest, and suggest that ...
2 provides a determination of the Bragg incidence angle dependence on acoustic frequency. If the incident beam is extraordinary polarized, then equations that couple 对wavevector图的分析在。 2提供Bragg入射角依赖性的决心对音响频率的。 如果 入射线是非凡对立,然后结合的等式 [translate] ...
Prucalopride (R093877) is a drug acting as a selective, high affinity 5-HT4 receptor agonist(pKi=8.6/8.1 for 5-HT4a/4b); >150-fold higher affinity for 5-HT4 receptors than for other receptors.IC50 value: 8.6/8.1 for 5-HT4a/4b(pKi)Target: 5-HT4 receptorPrucalopride is a novel ent...
Prucalopride is approved for the treatment of chronic constipation in Europe. Clinical Use Prucalopride succinate, a first-in-class dihydrobenzofurancarboxamide, is a selective serotonin (5- HT4) receptor agonist. The drug, marketed under the brand name Resolor?, possesses enterokinetic activity and...